Tolvaptan reduces eGFR decline in patients with polycystic kidney disease
1. Estimated glomerular filtration rate (eGFR) declined less over one year of treatment for patients with later-stage autosomal dominant polycystic ...
Tag: autosomal dominant polycystic kidney disease
2 Minute Medicine Rewind October 28 – November 3, 2013
Image: PD In this section, we will highlight the key high-impact studies, updates, and analyses published in medicine during the ...